Solid and sterile finished dosage forms. Delivered.

Similar documents
FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

innovative products. faster to market. reliably supplied.

innovative products. faster to market. reliably supplied.

Taking Health & Nutrition to the NEXT Level

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Pharmaceutical Preparation For Internal Use

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Partner with the Global Leader in Drug Delivery Systems

905 UNIFORMITY OF DOSAGE UNITS

CHEWABLE SOFTGEL TECHNOLOGY

SOFT GELATIN CAPSULE. Dr. Nawal Ayash

Differentiate your brand. with the unique look and performance of capsugel s press-fit and xpress-fit gelcaps. capsugel.com

REVISION OF MONOGRAPH ON TABLETS. Tablets

Enhanced delivery methods for greater efficacy

UNIT 2 SOLID AND LIQUID DOSAGE FORMS

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

Development of Nutrient Delivery Systems: Ingredients & Challenges

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

FLORITER. New Technology for Innovative Formulation Design.

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Large scale production

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

Unigel TM Case Study: Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations

SUMMARY AND CONCLUSION

Pediatric Formulation Development Industry Perspective on Palatability Challenges & Opportunities

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

Dr.J.S.Suresh kumar Nitta Gelatin India Limited P.B.No. 4262, 50/1002, SBT Avenue, Panampilly Nagar COCHIN KERALA.

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

PARENTERAL PREPARATIONS

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

PROCAPS at a glance. Experience with more that 650 softgel formulations, partnering with big pharma players, generic

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form

The unlocked synergy of DFE Pharma MCC

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

USP Chewable Gels Monographs

Advanced functional coating solutions for nutraceuticals

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

Innovations in Administration and Injection Systems EXPERIENCED CREATIVE FOCUSED

Challenges in Developing Stable and Efficient Probiotic Formulations

capsules and capsule filling

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

The Soft Gel Specialist

NUTRILO YOUR COMPETENT PARTNER IN DIETARY SUPPLEMENTS

Graft Delivery Devices

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Study of Consumer Preferences: Solid Oral Dosage Forms. Pharmaceutical n OTC n Dietary Supplement

Non-Food Uses of Polysaccharides

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

ANIMAL HEALTH DIVISION. Technologies & Services

Easy, fast and reliable!

A. General Appearance

The solid choice for Omega-3

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

The Wright Grou. the history of

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Kollicoat Smartseal 30 D Active Protection

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

Ayanda strives to be in the forefront of the business

Easy, fast and reliable!

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

Critical material properties for the design of robust drug products : excipient functionality related characteristics

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

EXCIPIENTS FOR PHARMACEUTICALS

Nutritional Products & Wellness Solutions. Your Source of Excellence

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

Division 1 Introduction to Advanced Prehospital Care

SPS Pharma: Who we are?

The Nutraceutical Solutions! CERTIFIED ISO

Delivery systems for nutraceuticals Enhanced bioavailability and improved functionality for lipophilic nutrients

Soluplus The Solid Solution Opening New Doors in Solubilization.

Why and how does a pharmaceutical company take the risk to use novel excipients?

Experience of paediatric formulations in Marketing Authorisatrion Applications

SCIENTIFIC DISCUSSION

THE DOSING SPECIALIST

Long-Term Care Updates

DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE

Food supplement manufacture

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

Tablets that melt in the mouth:

Excellence in Fixed Dose Combinations for Prevention & Nutrition. Softigel by Procaps Nutraceutical product line

Advanced functional coating solutions for nutraceuticals

Formulation factors affecting acceptability of oral medicines in children

Challenges and solutions for moisture sensitive API formulation

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

FILL AMOUNT CONTROL FOR LIQUID AND SEMISOLID DOSAGE FORMS

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE

Consumer Health Care V5.0_2013

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1

Revised European Guideline on PK and Clinical Evaluation of Modified Release Dosage Forms

ORAL DOSAGE OVERVIEW

Because you want to achieve your best possible health

PHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004

D9G : Oro-Mucosal Dosage Forms Development Background Paper

MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicin

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE

Transcription:

Solid and sterile finished dosage forms. Delivered.

This is where your discoveries take form. Oral Solids Access a remarkable range of conventional and specialized oral solid dosage form capabilities and scale. Further expand your options with innovative combinations of these forms and a variety of controlled-release technologies. All these choices are executed with expansive scientific resources, expertise in complex formulations such as, solubility enhancement and capabilities for highly potent compounds and controlled substances. Tap the many clinical and technical advantages of softgels with a host of patent-protected specialized technologies. These include advanced solutions for enhancing solubility and bioavailability, as well as unique controlledrelease and oral delivery technologies. Create a product that stands out in the marketplace with a broad palette of shapes, sizes and colors. s Extensive sterile pharmaceutical development and manufacturing capabilities at all scales. Specialized expertise in terminal sterilization, aseptic processes and lyophilization. Dosage formats include a wide array of vial shapes, sizes and stoppers. You ll also have access to a state-of-the-art, commercialscale cgmp manufacturing suite for prefilled syringes and cartridges. 30 pre-approval inspection waivers

Specialized oral solids Bilayer Tablets Trilayer Tablets 2 IRs or IR+CR/SR fixed-dose combination. 3 IRs or IR+placebo+CR/SR fixed-dose combination. Microtablets IR or CR/SR, low-dose tablets; via device, capsule or sachet. Tablets in Capsules IR or CR/SR, over-encapsulation for blinded clinical supply. Chewable Tablets IR or CR/SR, single or bilayer fixed-dose combinations. Ideal for pediatrics and high-dose compounds. Fast-Dispersible Tablets IR, disintegrates/disperses as suspension in water, divisible into 4 parts for titration. Ideal for pediatrics. Sublingual Tablets IR, single-layer tablets for sublingual administration. Beads in Hard-Shell Capsules IRs and/or CRs/SRs fixed-dose combination, uncoated or polymer coated; extrusion, spheronization or drug layering. Beads in Liquid-Filled Capsules IRs and/or CRs/SRs fixed-dose combination, hard shell, coated beads in liquid vehicle. Liquid-Filled Capsules IR or CR/SR, hard shell, options to improve solubility, bioavailability and absorption. Ideal for Phase I and beyond. Biphasic Liquid-Filled Capsules IR or CR/SR, hard shell, biphasic vehicle to improve solubility, bioavailability and absorption. Ideal for Phase I and beyond. Laser-Drilled Controlled-Release Tablets CR/SR, osmotic, zero-order, controlled-release over a defined time period. Hydrophilic Gel Matrix Polymer Matrix Wax Matrix Pulsatile Release Conventional oral solids Polymer Coating Tablets Powder-Filled Capsules IR or CR/SR, single-layer tablets, coated or uncoated, with or without break line or embossing, range of shapes and sizes. IR, two-piece gelatin or HPMC capsules in a range of sizes and multiple color combinations. Powders, Granules, Coated Beads and Multiparticulates IR, packaged in bottles and sachets of varying dimensions and fill weights.

Softgel Capsules Twist-Off EnteriCare Enteric Versatrol Controlled-Release Solvatrol Enhanced Solubility LiquiSoft Chewable Liquid-Filled Soflet Gelcaps Chewels Chewable Gels Immediate-release soft gelatin capsules. Clinical development scale production. 13.7B capsule commercial manufacturing capacity. Extensive range of sizes, colors and imprinting options. Precise unit dosing for oral liquid and topical products. Hermetic seal helps preserve API. Portable convenience improves patient compliance. Consistent dosing for reliable results in clinical trials. Enteric properties are integrated into the gelatin shell. Eliminates risk of reflux and gastric irritation. Protects acid-labile compounds. Compatible with SMEDDS, hydrophilic and viscous fills. Unique matrix system to fine-tune release. Controlled-release capabilities integrated into fill. Lipophilic and hydrophilic formulations. Suitable for compounds with low solubility. Enhances solubility and bioavailability. Lipophilic and hydrophilic formulations. Provides a stable solvent delivery system. Reduces plasma level variability. Solid dose for oral liquid formulations. b bsoft, chewable shell with a pleasant burst of liquid. Enhances performance of poorly soluble compounds. Flavors and aromas mask unpleasant tastes and odors. Patented technology enrobes tablets. Broad array of color and imprinting choices. Safely encases highly potent compounds. Perfect for clinical trial blinding. Chewable for patient comfort and convenience. Rapid onset of action and relief of symptoms. Ideal for pediatric and geriatric markets. Patented technology. Softgel shapes and sizes Oval Oblong Round Capsules Required Container Size (cc) by Fill Count Size Fill Volume Range (CC) 60 Count 100 Count 250 Count 500 Count 2 0.089-0.111 60 60 75 150 3 0.182-0.228 60 75 120 200 4 0.209-0.261 60 100 150 250 5 0.312-0.389 75 100 150 300 6 0.318-0.397 75 100 150 400 7.5 0.386-0.482 75 100 225 400 9 0.469-0.586 100 120 300 600 10 0.567-0.709 100 120 300 600 3 0.181-0.227 75 75 200 350 4 0.243-0.304 100 120 250 400 5 0.285-0.356 100 120 300 750 6 0.338-0.422 100 120 400 750 8 0.452-0.564 120 200 500 950 14 0.863-1.079 200 300 750 1250 16 0.975-1.218 250 400 950 1500 2 0.073-0.123 60 60 75 150 3 0.138-0.183 60 75 120 200 4 0.173-0.244 60 100 150 250 5 0.195-0.305 75 100 150 300 6 0.279-0.367 75 100 150 400 7 0.305-0.428 75 100 225 400 15 0.737-0.922 150 225 500 750 Other shapes and sizes available. Formulation can effect options.

s Liquid-Filled Vials Lyophilized Vials Prefilled Syringes Aseptic filling, terminal sterilization when required. Solutions, suspensions or emulsions. Extensive range of sizes and stopper/cap combinations. Clear or amber glass. World-class scientific and technical expertise. Wide selection of vial sizes, including ISO standard. Small- and large-scale manufacturing. Broad range of sizes and configurations with handles. Fill range from 0.1 ml to 20 ml. Glass or polymeric. Cartridges Range of cartridge configurations. Glass or polymeric. Liquid-Filled Vial Lyophilized Vial Dosage Format Commercial Development Vial Size* (ml) Stopper Size (mm) Greenville, Ferentino, Monza, Greenville, Ferentino, 2 13 4 13 5 20 6 20 7 20 8 20 10 20 12 20 13 13 15 20 20 20/13 25 20 30 20 50 20/32 60 28 100 20/28/32 200 28/32 250 32 300 28 500 28/32 2 13/20 3 13 4 13 5 13/20 6 20 7 20 8 20 10 20 12 20 15 20 17 20 20 20 25 20 30 20 50 20 100 20 Lyophilization batch sizes for the most available vial sizes. External OD (mm) Vial Size Example Fill Line 1 Line 2 Line 3 3 Lyo Units 3 Lyo Units Greenville, Ferentino, Monza, 3 Lyo Units Cytotoxic CTM Area 1 Lyo Unit 1 Area 2 Lyo Unit 2 Area 2 Development Unit Area 1 2 Twin Lyo Units Area 2 2 Twin Lyo Units Area 3 2 Twin Lyo Units 16 2, 4 490,000 318,000 329,000 43,000 8,600 120,000 153,000 37,000 24,000 138,000 111,000 127,000 21 5 295,000 200,000 206,000 27,000 5,400 69,000 89,000 19,000 14,000 81,000 65,000 74,000 22 6 265,000 179,000 185,000 24,000 4,800 67,000 86,000 18,000 12,500 73,000 58,000 67,000 24 10, 15 174,000 117,000 121,000 16,000 3,200 55,000 69,000 14,000 10,000 61,000 49,000 55,000 30 20, 25, 30 142,000 95,000 98,000 13,000 2,600 35,000 45,000 9,500 6,400 37,000 30,000 35,000 42 15 65,000 42,000 44,000 5,000 1,000 17,000 22,000 4,700 3,500 17,000 13,000 15,000 * ISO standard and non-standard vials can be accommodated.

A world of choices. Delivered. Cincinnati High Point North America Greenville Toronto Canada Whitby Canada Manati Bourgoin Puerto Rico France Monza Ferentino Europe Milton Park U.K. Swindon U.K. Tilburg Netherlands Oral Solid Dosage Forms Specialized Conventional Bilayer Tablets Trilayer Tablets Microtablets Beads in Capsules Coated Beads Tablets in Capsules Fast-Dispersible Tablets Laser-Drilled Controlled-Release Tablets Liquid-Filled Capsules Biphasic Liquid-Filled Capsules Bilayer Chewable Tablets Beads in Liquid-Filled Capsules Hydrophilic Gel Matrix Polymer Matrix Wax Matrix Pulsatile Release Polymer Coating Sublingual Tablets Uncoated Coated Powder-Filled Capsules Powders and Granules Multiparticulates Softgel Capsules Twist-Off EnteriCare Enteric LiquiSoft Chewable Liquid-Filled Versatrol Controlled-Release Solvatrol Enhanced Solubility Dosage Forms Soflet Gelcaps Chewels Chewable Gels Liquid-Filled Vials Lyophilized Vials Prefilled Syringes Cartridges

+1 866.PATHEON www.patheon.com doingbusiness@patheon.com

80% of our clients are emerging or midsize 75 number of countries products we make are distributed to 33% of products we develop, we manufacture Patheon 4815 Emperor Blvd, Suite 300 Durham NC 27703-8470 P: +1 919 226 3200 F: +1 919 474 2269 www.patheon.com Patheon Kingfisher Drive Covingham, Swindon Wiltshire SN3 5BZ UK P: +44 1793 524411 F: +44 1793 487053 www.patheon.com Patheon 7F Wakamatsu Building, 3-3-6 Nihonbashi Hon-cho, Chuo-ku, Tokyo 103-0023 Japan P: +81 3 6202 7666 F: +81 3 6202 7676 www.patheon.jp +1 866.PATHEON a www.patheon.com a doingbusiness@patheon.com Published 9/15 PATH0340R3